Bio-Gene Technology Gross Profit vs. Beta
| BGT Stock | 0.03 0 10.00% |
Gross Profit | First Reported 2013-12-31 | Previous Quarter -171.5 K | Current Value -130 K | Quarterly Volatility 134.5 K |
For Bio-Gene Technology profitability analysis, we use financial ratios and fundamental drivers that measure the ability of Bio-Gene Technology to generate income relative to revenue, assets, operating costs, and current equity. These fundamental indicators attest to how well Bio Gene Technology utilizes its assets to generate profit and value for its shareholders. The profitability module also shows relationships between Bio-Gene Technology's most relevant fundamental drivers. It provides multiple suggestions of what could affect the performance of Bio Gene Technology over time as well as its relative position and ranking within its peers.
Bio-Gene |
Bio Gene Technology Beta vs. Gross Profit Fundamental Analysis
Comparative valuation techniques use various fundamental indicators to help in determining Bio-Gene Technology's current stock value. Our valuation model uses many indicators to compare Bio-Gene Technology value to that of its competitors to determine the firm's financial worth. Bio Gene Technology is number one stock in gross profit category among its peers. It also is number one stock in beta category among its peers . At this time, Bio-Gene Technology's Gross Profit is comparatively stable compared to the past year. The reason why the comparable model can be used in almost all circumstances is due to the vast number of multiples that can be utilized, such as the price-to-earnings (P/E), price-to-book (P/B), price-to-sales (P/S), price-to-cash flow (P/CF), and many others. The P/E ratio is the most commonly used of these ratios because it focuses on the Bio-Gene Technology's earnings, one of the primary drivers of an investment's value.Bio-Gene Beta vs. Gross Profit
Gross Profit is the most basic measure of business operational efficiency. It is simply the difference between sales revenue and the cost associated with making a product or providing a service. It is calculated before deducting administrative expenses, taxes, and interest payments.
Bio-Gene Technology |
| = | (558.91 K) |
Gross Profit varies significantly from one sector to another and tells an investor how much money a business would have made if it didn't have to pay any overhead expenses such as salary, taxes, or rent.
Beta is one of the most important measures of equity market volatility. Beta can be thought of as asset elasticity or sensitivity to market. In other words, it is a number that shows the relationship of an equity instrument to the financial market in which this instrument is traded. For example, if Beta of equity is 2, it is expected to significantly outperform market when the market is going up and significantly underperform when the market is going down. Similarly, Beta of 1 indicates that an asset and market will generate similar returns over time.
Bio-Gene Technology |
| = | 0.64 |
In a nutshell, Beta is a measure of individual stock risk relative to the overall volatility of the stock market. and is calculated based on very sound finance theory - Capital Assets Pricing Model (CAPM).However, since Beta is calculated based on historical price movements it may not predict how a firm's stock is going to perform in the future.
Bio-Gene Beta Comparison
Bio Gene is currently under evaluation in beta category among its peers.
Beta Analysis
As returns on the market increase, Bio-Gene Technology's returns are expected to increase less than the market. However, during the bear market, the loss of holding Bio-Gene Technology is expected to be smaller as well.
Bio-Gene Technology Profitability Projections
The most important aspect of a successful company is its ability to generate a profit. For investors in Bio-Gene Technology, profitability is also one of the essential criteria for including it into their portfolios because, without profit, Bio-Gene Technology will eventually generate negative long term returns. The profitability progress is the general direction of Bio-Gene Technology's change in net profit over the period of time. It can combine multiple indicators of Bio-Gene Technology, where stable trends show no significant progress. An accelerating trend is seen as positive, while a decreasing one is unfavorable. A rising trend means that profits are rising, and operational efficiency may be rising as well. A decreasing trend is a sign of poor performance and may indicate upcoming losses.
| Last Reported | Projected for Next Year | ||
| Accumulated Other Comprehensive Income | 1 M | 743.2 K | |
| Operating Income | -2.8 M | -2.9 M | |
| Net Loss | -2.2 M | -2.3 M | |
| Income Before Tax | -2.7 M | -2.8 M | |
| Total Other Income Expense Net | 56.5 K | 53.6 K | |
| Net Loss | -2.8 M | -2.6 M | |
| Net Loss | -2.2 M | -2.3 M | |
| Income Tax Expense | -543.8 K | -516.6 K | |
| Net Interest Income | 78.3 K | 60.4 K | |
| Interest Income | 78.3 K | 60.7 K | |
| Change To Netincome | 562.1 K | 590.2 K |
Bio-Gene Profitability Driver Comparison
Profitability drivers are factors that can directly affect your investment outlook on Bio-Gene Technology. Investors often realize that things won't turn out the way they predict. There are maybe way too many unforeseen events and contingencies during the holding period of Bio-Gene Technology position where the market behavior may be hard to predict, tax policy changes, gold or oil price hikes, calamities change, and many others. The question is, are you prepared for these unexpected events? Although some of these situations are obviously beyond your control, you can still follow the important profit indicators to know where you should focus on when things like this occur. Below are some of the Bio-Gene Technology's important profitability drivers and their relationship over time.
Use Bio-Gene Technology in pair-trading
One of the main advantages of trading using pair correlations is that every trade hedges away some risk. Because there are two separate transactions required, even if Bio-Gene Technology position performs unexpectedly, the other equity can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Bio-Gene Technology will appreciate offsetting losses from the drop in the long position's value.Bio-Gene Technology Pair Trading
Bio Gene Technology Pair Trading Analysis
The ability to find closely correlated positions to Bio-Gene Technology could be a great tool in your tax-loss harvesting strategies, allowing investors a quick way to find a similar-enough asset to replace Bio-Gene Technology when you sell it. If you don't do this, your portfolio allocation will be skewed against your target asset allocation. So, investors can't just sell and buy back Bio-Gene Technology - that would be a violation of the tax code under the "wash sale" rule, and this is why you need to find a similar enough asset and use the proceeds from selling Bio Gene Technology to buy it.
The correlation of Bio-Gene Technology is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A perfect positive correlation (i.e., a correlation coefficient of +1) implies that as Bio-Gene Technology moves, either up or down, the other security will move in the same direction. Alternatively, perfect negative correlation means that if Bio Gene Technology moves in either direction, the perfectly negatively correlated security will move in the opposite direction. If the correlation is 0, the equities are not correlated; they are entirely random. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.
Correlation analysis and pair trading evaluation for Bio-Gene Technology can also be used as hedging techniques within a particular sector or industry or even over random equities to generate a better risk-adjusted return on your portfolios.Use Investing Themes to Complement your Bio-Gene Technology position
In addition to having Bio-Gene Technology in your portfolios, you can quickly add positions using our predefined set of ideas and optimize them against your very unique investing style. A single investing idea is a collection of funds, stocks, ETFs, or cryptocurrencies that are programmatically selected from a pull of investment themes. After you determine your investment opportunity, you can then find an optimal portfolio that will maximize potential returns on the chosen idea or minimize its exposure to market volatility.Did You Try This Idea?
Run Money Market Funds Thematic Idea Now
Money Market Funds
Funds or Etfs investing in various types of short-term (less than one year) fixed income instruments of high-quality and liquidity. The Money Market Funds theme has 47 constituents at this time.
You can either use a buy-and-hold strategy to lock in the entire theme or actively trade it to take advantage of the short-term price volatility of individual constituents. Macroaxis can help you discover thousands of investment opportunities in different asset classes. In addition, you can partner with us for reliable portfolio optimization as you plan to utilize Money Market Funds Theme or any other thematic opportunities.
| View All Next | Launch |
Additional Tools for Bio-Gene Stock Analysis
When running Bio-Gene Technology's price analysis, check to measure Bio-Gene Technology's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Bio-Gene Technology is operating at the current time. Most of Bio-Gene Technology's value examination focuses on studying past and present price action to predict the probability of Bio-Gene Technology's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Bio-Gene Technology's price. Additionally, you may evaluate how the addition of Bio-Gene Technology to your portfolios can decrease your overall portfolio volatility.